PAR Announces Investment Opinion on MedCare Technologies, Inc.NEW YORK--(BUSINESS WIRE)--Nov. 22, 1999-- A Quarterly update report covering MedCare Technologies, Inc. (Nasdaq:MCAR MCAR Missing Completely At Random MCAR Military Construction, Army Reserve MCAR Marine Corps Air Station MCAR Machine Check Analysis and Recording MCAR Multiple Channel Aural Reception MCAR Multichannel Acoustic Relay MCAR Mobile Cosmetic Auto Repairs ) by PAR Analyst John M. Dutton was released today for Public Analysis & Review (PAR). PAR is the unique professional independent security analyst program administered by the non-profit Investors Research Institute, Inc., and Investrend Research distributes the PAR program reports. According to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. Gayle Essary, Investrend Research president, Mr. Dutton established a NEUTRAL rating on the stock. However, Mr. Dutton noted, this rating would be increased to BUY if their new business model for the MedCare Program and Rxsheets.com is able to produce expected results in the next several months. A copy of the Quarterly Review Report, also in Adobe adobe (ədō`bē): see rammed earth. adobe Handmade sun-dried bricks formed from a mixture of heavy clay and straw found in arid regions. pdf format, is available from the Investrend web site at www.investrend.com. A summary of Mr. Dutton's conclusions follows: A NEUTRAL rating on the shares of MedCare rating reflects the lack of positive operating results since May, with reported results substantially below our projected levels. However, we note that there have been many potentially positive changes to the Company's business models. As results under the new models become apparent, the neutral stock rating will be revisited. MedCare Technologies and its MedCare program, is the largest program using behavioral behavioral pertaining to behavior. behavioral disorders see vice. behavioral seizure see psychomotor seizure. modification to treat incontinence incontinence Inability to control excretion. Starting and stopping urination relies on normal function in pelvic and abdominal muscles, diaphragm, and control nerves. Babies' nervous systems are too immature for urinary control. Later incontinence may reflect disorders (e.g. . This approach is endorsed by the AMA (Automatic Message Accounting) The recording and reporting of telephone calls within a telephone system. It includes the calling and called parties and start and stop times of the call. and the US Dept. of Health Services health services Managed care The benefits covered under a health contract . The Company has now targeted the hospital market as the primary market to base its MedCare Program. Two excellent hospitals as of this date have signed with MCAR. Management believes it will shortly announce a third. We believe they are on the right track. By any measure, the incontinence treatment market is in billions of dollars annually. The MedCare Program benefits all concerned, patient, doctor, and insurance provider. The market is untapped except for the less desirable alternatives of pharmacological Pharmacological Referring to therapy that relies on drugs. Mentioned in: Pain Management pharmacological, pharmacologic pertaining to pharmacology. and surgery. In the middle of changing its MedCare Program business model, major changes were made to its original Internet based program, Medcareonline. This was replaced with an interesting physician service called Rxsheets.com announced during the recent quarter. Results in the form of partnering with drug companies are expected in the next several months. The present NEUTRAL rating on the stock reflects the need of the Company to demonstrate results under its new business models. We believe the Company may at last be on the right track, in which case the stock rating will be revisited. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion